UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   Form 10-QSB


(Mark one)

[X]  Quarterly  Report Under Section 13 or 15(d) of The Securities  Exchange Act
     of 1934

For the quarterly period ended September 30, 2004

[_]  Transition Report Under Section 13 or 15(d) of The Securities  Exchange Act
     of 1934

For the transition period from ______________ to _____________


Commission File Number: 0-32379

                            American Ammunition, Inc.
                -----------------------------------------------
        (Exact name of small business issuer as specified in its charter)


        California                                           91-2021594
--------------------------                          ----------------------------
(State of incorporation)                             (IRS Employer ID Number)


                      3545 NW 71st Street, Miami, FL 33147
                      ------------------------------------
                    (Address of principal executive offices)


                                 (305) 835-7400
                      ------------------------------------
                           (Issuer's telephone number)


---------------

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. YES [X] NO [_]


State the number of shares outstanding of each of the issuer's classes of common
equity as of November 18, 2004: 74,740,580


Transitional Small Business Disclosure Format (check one):    YES [_]  NO [X]

---------------






                            American Ammunition, Inc.

              Form 10-QSB for the Quarter ended September 30, 2004




                                Table of Contents


                                                                           Page
Part I - Financial Information

  Item 1 Financial Statements                                                  3

  Item 2 Management's Discussion and Analysis or Plan of Operation            22

  Item 3 Controls and Procedures                                              27


Part II - Other Information

  Item 1 Legal Proceedings                                                    28

  Item 2 Recent Sales of Unregistered Securities and Use of Proceeds          28

  Item 3 Defaults Upon Senior Securities                                      28

  Item 4 Submission of Matters to a Vote of Security Holders                  28

  Item 5 Other Information                                                    28

  Item 6 Exhibits                                                             29


Signatures 29






                                     Part I

Item 1 - Financial Statements




                   American Ammunition, Inc. and Subsidiaries
                           Consolidated Balance Sheets
                           September 30, 2004 and 2003

                                   (Unaudited)

                                                                September 30,   September 30,
                                                                    2004             2003
                                                                ------------    ------------
                                                                                    
                                     ASSETS
Current Assets
   Cash on hand and in bank                                     $    658,641    $  1,347,532
   Accounts receivable - trade, net allowance for
     doubtful accounts of $-0- and $-0-, respectively                255,236         288,503
   Inventory                                                       1,025,824         651,097
   Prepaid expenses                                                   62,725          36,421
                                                                ------------    ------------

     Total Current Assets                                          2,002,426       2,323,553
                                                                ------------    ------------


Property and Equipment - at cost or contributed value
   Manufacturing equipment                                         7,623,415       6,895,850
   Office furniture and fixtures                                      82,719          62,893
   Leasehold improvements                                            187,397         190,028
                                                                ------------    ------------
                                                                   7,893,531       7,148,771
   Accumulated depreciation                                       (4,595,887)     (3,891,321)
                                                                ------------    ------------

     Net Property and Equipment                                   3,297,644       3,257,450
                                                                ------------    ------------


Other Assets
   Deposits and other                                                415,000          77,860
                                                                ------------    ------------

TOTAL ASSETS                                                    $  5,715,070    $  5,658,863
                                                                ============    ============




                                  - Continued -




   The accompanying notes are an integral part of these financial statements.

The  financial  information  presented  herein has been  prepared by  management
without audit by independent certified public accountants.

                                                                               3







                   American Ammunition, Inc. and Subsidiaries
                     Consolidated Balance Sheets - Continued
                           September 30, 2004 and 2003

                                   (Unaudited)

                                                                September 30,   September 30,
                                                                    2004             2003
                                                                ------------    ------------
                                                                                    
                    LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities
   Current maturities of leases payable                         $        525    $      9,507
   Customer deposits                                                 220,006           4,100
   Accounts payable - trade                                          665,077         471,085
   Working capital advance                                            74,000         400,000
   Accrued payroll payable                                            54,445          28,810
   Accrued dividends payable                                          13,421          34,261
                                                                ------------    ------------

     Total Current Liabilities                                     1,042,474         947,763

Long-Term Liabilities                                                      -               -
   Capital leases payable                                                  -             828
                                                                ------------    ------------

     Total Liabilities                                          $  1,042,474    $    948,591
                                                                ------------    ------------

Commitments and Contingencies

Convertible Debenture                                                266,365         431,365
                                                                ------------    ------------

Mandatory Convertible Preferred Stock
   net of Beneficial Conversion Discount Feature
     91,700 and 123,700 shares issued and outstanding                518,500         602,610
                                                                ------------    ------------

Stockholders' Equity
   Preferred stock - $0.001 par value
     20,000,000 shares authorized.
     1,795,320 shares allocated to Series A                                -               -
     1,000,000 shares allocated to Series B                                -               -
   Common stock - $0.001 par value.
     300,000,000 shares authorized.
     73,686,672 and 62,718,137 shares issued
      and outstanding                                                 73,687          62,718
   Additional paid-in capital                                     23,098,312      19,961,671
   Accumulated deficit                                           (19,009,268)    (16,348,092)
                                                                ------------    ------------
                                                                   4,162,731       3,676,297
   Stock subscription receivable                                    (275,000)              -
                                                                ------------    ------------

   Total Stockholders' Equity                                      3,887,731       3,676,297
                                                                ------------    ------------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                      $  5,715,070    $  5,658,863
                                                                ============    ============




   The accompanying notes are an integral part of these financial statements.

The  financial  information  presented  herein has been  prepared by  management
without audit by independent certified public accountants.

                                                                               3






                   American Ammunition, Inc. and Subsidiaries
      Consolidated Statements of Operations and Comprehensive Income (Loss)
             Nine and Three months ended September 30, 2004 and 2003

                                   (Unaudited)

                                              Nine months       Nine months     Three months      Three months
                                                 ended             ended           ended             ended
                                             September 30,      September 30,   September 30,     September 30,
                                                 2004              2003              2004              2003
                                             ---------------  ----------------  ----------------  -------------
                                                                                                 

Revenues                                     $     1,712,280  $      1,215,717  $        861,988  $     317,729
                                             ---------------  ----------------  ----------------  -------------

Cost of Sales
   Materials, Direct Labor
      and other direct costs                       1,911,210         1,713,888           308,503        614,748
   Depreciation                                      523,815           494,633           176,304        165,464
                                             ---------------  ----------------  ----------------  -------------
      Total Cost of Sales                          2,435,025         2,208,521           484,807        780,212
                                             ---------------  ----------------  ----------------  -------------

Gross Profit                                        (722,745)         (992,804)          377,181       (462,483)
                                             ---------------  ----------------  ----------------  -------------

Operating Expenses
   Research and development expenses                   8,332             9,208             1,858          8,824
   Marketing and promotion expenses                  368,458            30,350           114,404         16,835
   Other operating expenses                          845,663           788,599           250,570        330,127
   Bad debt expense                                   27,819                 -                 -              -
   Interest expense                                   15,825            26,270                58          9,725
   Depreciation expense                                5,681             3,387             1,894          1,129
   Compensation expense related to
      common stock issuances at less
      than "fair value"                              356,000           736,102                 -        371,798
                                             ---------------  ----------------  ----------------  -------------
      Total Operating Expenses                     1,627,778         1,593,916           368,784        738,498
                                             ---------------  ----------------  ----------------  -------------

Loss from Operations                              (2,350,523)       (2,586,720)            8,397     (1,200,981)

Other Income (Expense)
   Interest and other income                           1,409             2,594             1,155              -
   Amortization of Beneficial
      Conversion Feature Discount
      on Preferred Stock                                   -           (77,787)                -        (46,839)
                                             ---------------  ----------------  ----------------  -------------
Loss before Income Taxes                          (2,349,114)       (2,661,913)            9,552     (1,247,820)
Provision for Income Taxes                                 -                 -                 -              -
                                             ---------------  ----------------  ----------------  -------------

Net Loss                                          (2,349,114)       (2,661,913)            9,552     (1,247,820)
Other Comprehensive Income                                 -                 -                 -              -
                                             ---------------  ----------------  ----------------  -------------

Comprehensive Loss                           $    (2,349,114) $     (2,661,913) $          9,552  $  (1,248,820)
                                             ===============  ================  ================  =============

Loss per weighted-average share of
   common stock outstanding, computed
   on net loss - basic and fully diluted     $         (0.03) $          (0.04) $          (0.00) $       (0.02)
                                             ===============  ================  ================  =============
Weighted-average number of
   common shares outstanding                      70,873,791        59,222,995        73,673,416     61,683,424
                                             ===============  ================  ================  =============


   The accompanying notes are an integral part of these financial statements.

The  financial  information  presented  herein has been  prepared by  management
without audit by independent certified public accountants.

                                                                               3






                   American Ammunition, Inc. and Subsidiaries
                      Consolidated Statements of Cash Flows
                  Nine months ended September 30, 2004 and 2003

                                   (Unaudited)

                                                                  Nine months   Nine months
                                                                     ended          ended
                                                                 September 30,  September 30,
                                                                     2004           2003
                                                                 -------------- -------------
                                                                                     
Cash flows from operating activities
   Net loss for the year                                         $   (2,349,114)$  (2,661,913)
   Adjustments to reconcile net loss to
     net cash provided by operating activities
       Depreciation and amortization                                    529,496       498,020
       Bad debt expense                                                  27,819             -
       Accretion of Beneficial Conversion Feature
         Discount on Preferred Stock                                          -        77,787
       Compensation expense related to common stock
         issuances at less than "fair value"                            356,000       736,102
       Common stock issued for fees and services                         90,160             -
       (Increase) Decrease in
         Accounts receivable                                            237,780      (257,215)
         Inventory                                                       86,932      (266,283)
         Prepaid expenses, deposits and other                           (28,137)      (17,030)
       Increase (Decrease) in
         Accounts payable - trade                                        36,213        56,175
         Other accrued expenses                                          54,445        10,101
         Customer deposits                                              215,906       (76,853)
                                                                 -------------- -------------
Net cash used in operating activities                                  (727,500)   (1,901,109)
                                                                 -------------- -------------

Cash flows from investing activities
   Purchase of property and equipment                                  (436,214)      (58,845)
                                                                 -------------- -------------
Net cash used in investing activities                                  (436,214)      (58,845)
                                                                 -------------- -------------

Cash flows from financing activities
   Funding of working capital advance                                    74,000       400,000
   Principal paid on long-term debt                                           -      (450,000)
   Principal paid on long-term capital leases                            (7,316)       (7,013)
   Cash paid to obtain capital                                                -       (61,850)
   Cash received on convertible debenture                                     -       350,000
   Cash received on sale of convertible preferred stock                       -       458,500
   Cash received on sale of common stock                              1,250,000     2,460,533
                                                                 -------------- -------------
Net cash provided by financing activities                             1,316,684     3,150,170
                                                                 -------------- -------------

Increase (Decrease) in Cash                                             152,970     1,190,216

Cash at beginning of year                                               505,671       157,316
                                                                 -------------- -------------

Cash at end of year                                              $      658,641 $   1,347,532
                                                                 ============== =============



                                  - Continued -


   The accompanying notes are an integral part of these financial statements.

The  financial  information  presented  herein has been  prepared by  management
without audit by independent certified public accountants.

                                                                               3






                   American Ammunition, Inc. and Subsidiaries
                      Consolidated Statements of Cash Flows
                  Nine months ended September 30, 2004 and 2003

                                   (Unaudited)

                                                                  Nine months   Nine months
                                                                     ended          ended
                                                                 September 30,  September 30,
                                                                     2004           2003
                                                                 -------------- -------------
                                                                                     
Supplemental disclosure of interest
   and income taxes paid
     Interest paid for the period                                $          825 $      26,170
                                                                 ============== =============
     Income taxes paid for the period                            $            - $           -
                                                                 ============== =============

Supplemental disclosure of non-cash
   investing and financing activities
     Asset purchase agreement for equipment,
       inventory and intellectual property
       accrued as a component of accounts payable                $      500,000 $          -
                                                                 ============== =============









                (Remainder of this page left blank intentionally)







   The accompanying notes are an integral part of these financial statements.

The  financial  information  presented  herein has been  prepared by  management
without audit by independent certified public accountants.

                                                                               3




                   American Ammunition, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


Note A - Organization and Description of Business

     American Ammunition,  Inc. (AAI or Company) was incorporated on February 1,
2000 in the State of California as FirsTelevision.com.  AAI subsequently changed
its  corporate  name to FBI Fresh  Burgers  International  which  unsuccessfully
marketed a business plan concept of a national "fast food" restaurant chain.

     On September  29, 2001,  the Company,  F&F  Equipment,  Inc.  (F&F) and the
individual  shareholders  of F&F entered into an "Agreement  For The Exchange Of
Common Stock"  (Exchange  Agreement)  whereby the  shareholders of F&F exchanged
100.0% of the issued and  outstanding  stock of F&F for 21,000,000  post-forward
split  shares of  restricted,  unregistered  common  stock of the  Company.  F&F
Equipment, Inc. then became a wholly-owned subsidiary of the Company.

     F&F Equipment,  Inc.(Company) was incorporated on October 4, 1983 under the
laws of the State of Florida.  The Company was formed to engage  principally  in
the  "import,  export,  retail & wholesale of firearms  equipment,  ammunition &
other  devices  and for  the  purpose  of  transacting  any  and/or  all  lawful
business." The Company  conducts its business  operations under the assumed name
of "American Ammunition".

     In June 2002, American  Ammunition,  Inc. formed a wholly owned subsidiary,
Industrial  Plating  Enterprise Co. (IPE),  which started production on June 14,
2002.  IPE is a fully  licensed  and approved  state of the art  electrochemical
metallization  facility for processing the Company's line of projectiles as well
as other  products  and services  while  employing  environmentally  sound water
conservation  and proven  waste  treatment  techniques.  The  facility  meets or
exceeds all current  environmental  requirements  and enjoys the  "conditionally
exempt small quantity generator" status for State and Federal regulations.


Note B - Preparation of Financial Statements

     The  acquisition  of F&F  Equipment,  Inc.,  on September  29, 2001, by the
Company  effected  a change  in  control  and was  accounted  for as a  "reverse
acquisition"  whereby  F&F  Equipment,  Inc.  was the  accounting  acquiror  for
financial statement purposes.  Accordingly,  the historical financial statements
of the Company are those of F&F Equipment, Inc. from it's inception and those of
the consolidated entity subsequent to the September 29, 2001 transaction date.

     The Company and its subsidiaries  follow the accrual basis of accounting in
accordance with accounting principles generally accepted in the United States of
America and have adopted a year-end of December 31 for all entities.

     The  preparation  of financial  statements  in conformity  with  accounting
principles   generally  accepted  in  the  United  States  of  America  requires
management to make estimates and assumptions that affect the reported amounts of
assets and  liabilities  and disclosure of contingent  assets and liabilities at
the date of the financial  statements  and the reported  amounts of revenues and
expenses  during the reporting  period.  Actual  results could differ from those
estimates.

     Management further  acknowledges that it is solely responsible for adopting
sound  accounting  practices,  establishing and maintaining a system of internal
accounting  control and preventing and detecting  fraud. The Company's system of
internal  accounting  control is designed to assure,  among other items, that 1)
recorded  transactions  are valid; 2) valid  transactions  are recorded;  and 3)
transactions  are  recorded in the proper  period in a timely  manner to produce
financial  statements which present fairly the financial  condition,  results of
operations  and cash  flows of the  Company  for the  respective  periods  being
presented


                                                                               8





                   American Ammunition, Inc. and Subsidiaries

                   Notes to Consolidated Financial Statements


Note B - Preparation of Financial Statements - Continued

     For segment reporting  purposes,  the Company operated in only one industry
segment during the periods represented in the accompanying  financial statements
and makes all  operating  decisions and  allocates  resources  based on the best
benefit to the Company as a whole.

     During interim  periods,  the Company  follows the accounting  policies set
forth in its annual audited financial statements filed with the U. S. Securities
and Exchange  Commission  on its Annual Report on Form 10-KSB for the year ended
December 31, 2003.  The  information  presented  within these interim  financial
statements  may not include all  disclosures  required by accounting  principles
generally  accepted in the United  States of America and the users of  financial
information  provided for interim  periods should refer to the annual  financial
information and footnotes when reviewing the interim financial results presented
herein.

     In  the  opinion  of  management,   the  accompanying   interim   financial
statements,  prepared  in  accordance  with the U. S.  Securities  and  Exchange
Commission's  instructions  for Form  10-QSB,  are  unaudited  and  contain  all
material adjustments,  consisting only of normal recurring adjustments necessary
to present fairly the financial condition,  results of operations and cash flows
of the Company for the respective interim periods presented.  The current period
results of operations are not necessarily indicative of results which ultimately
will be reported for the full fiscal year ending December 31, 2004.

     The accompanying  consolidated financial statements contain the accounts of
American Ammunition, Inc. and its wholly-owned subsidiaries, F&F Equipment, Inc.
and Industrial Plating Enterprise Co. All significant intercompany  transactions
have been eliminated.  The consolidated entities are collectively referred to as
"Company".


Note C - Summary of Significant Accounting Policies

1.   Cash and cash equivalents

          For Statement of Cash Flows purposes,  the Company  considers all cash
     on hand and in banks,  certificates  of  deposit  and  other  highly-liquid
     investments with maturities of three months or less, when purchased,  to be
     cash and cash equivalents.

          Cash overdraft positions may occur from time to time due to the timing
     of making bank  deposits  and  releasing  checks,  in  accordance  with the
     Company's cash management policies.


2.   Accounts receivable and Revenue Recognition

          In the normal course of business, the Company extends unsecured credit
     to virtually all of its customers  which are located  throughout the United
     States.  Because of the credit risk  involved,  management  has provided an
     allowance for doubtful accounts which reflects its opinion of amounts which
     will   eventually   become   uncollectible.   In  the  event  of   complete
     non-performance, the maximum exposure to the Company is the recorded amount
     of trade  accounts  receivable  shown on the  balance  sheet at the date of
     non-performance.

          The Company  ships all  product on an  FOB-Plant  basis.  Accordingly,
     revenue  is  recognized  by the  Company  at the point at which an order is
     shipped at a fixed price, collection is reasonably assured, the Company has
     no  remaining  performance  obligations  and  no  right  of  return  by the
     purchaser exists.


                                                                               9





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note C - Summary of Significant Accounting Policies - Continued

3.   Inventory

          Inventory  consists of raw  materials,  work-in-process  and  finished
     goods  related  to the  production  and  sale  of  small  arms  ammunition.
     Inventory  is valued at the  lower of cost or  market  using the  first-in,
     first-out method.


4.   Property, plant and equipment

          Property and equipment are recorded at  historical  cost.  These costs
     are depreciated  over the estimated  useful lives of the individual  assets
     using the straight-line method, generally three to ten years.

          Gains and losses  from  disposition  of  property  and  equipment  are
     recognized as incurred and are included in operations.


5.   Income Taxes

          The Company  uses the asset and  liability  method of  accounting  for
     income taxes.  At September  30, 2004 and 2003,  the deferred tax asset and
     deferred tax liability accounts, as recorded when material to the financial
     statements,  are entirely the result of  temporary  differences.  Temporary
     differences   represent  differences  in  the  recognition  of  assets  and
     liabilities for tax and financial reporting purposes, primarily accumulated
     depreciation and amortization, allowance for doubtful accounts and vacation
     accruals.

          As of September  30, 2004 and 2003,  the deferred tax asset related to
     the Company's net operating loss  carryforward is fully reserved.  If these
     carryforwards are not utilized, they will begin to expire in 2005.

6.   Earnings (loss) per share

          Basic earnings (loss) per share is computed by dividing the net income
     (loss) available to common shareholders by the  weighted-average  number of
     common shares  outstanding  during the respective  period  presented in our
     accompanying financial statements.  Fully diluted earnings (loss) per share
     is  computed  similar  to basic  income  (loss) per share  except  that the
     denominator is increased to include the number of common stock  equivalents
     (primarily  outstanding  options and  warrants).  Common stock  equivalents
     represent the dilutive  effect of the assumed  exercise of the  outstanding
     stock options and warrants,  using the treasury stock method, at either the
     beginning  of the  respective  period  presented  or the date of  issuance,
     whichever is later, and only if the common stock equivalents are considered
     dilutive  based  upon the  Company's  net  income  (loss)  position  at the
     calculation date.

          At  September  30,  2004 and 2003,  the  Company  had no common  stock
     equivalents outstanding.


7.   Advertising costs

          The  Company  does  not  conduct  any  direct   response   advertising
     activities.  For non-direct response  advertising,  the Company charges the
     costs of  these  efforts  to  operations  at the  first  time  the  related
     advertising is published.


                                                                              10





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note D - Fair Value of Financial Instruments

     The carrying  amount of cash,  accounts  receivable,  accounts  payable and
notes  payable,  as  applicable,  approximates  fair value due to the short term
nature of these items and/or the current  interest  rates payable in relation to
current market conditions.

     Interest rate risk is the risk that the  Company's  earnings are subject to
fluctuations  in interest  rates on either  investments  or on debt and is fully
dependent  upon  the  volatility  of  these  rates.  The  Company  does  not use
derivative instruments to moderate its exposure to interest rate risk, if any.

Financial risk is the risk that the Company's earnings are subject to
fluctuations in interest rates or foreign exchange rates and are fully dependent
upon the volatility of these rates. The company does not use derivative
instruments to moderate its exposure to financial risk, if any.


Note E - Concentrations of Credit Risk

     The Company maintains its cash accounts in a financial  institution subject
to  insurance  coverage  issued by the  Federal  Deposit  Insurance  Corporation
(FDIC).  Under FDIC rules, the separate companies are each entitled to aggregate
coverage of $100,000 per account type per  separate  legal entity per  financial
institution.  During the years ended December 31, 2003 and 2002 and for the nine
month  period ended  September  30, 2004,  respectively,  the various  operating
companies had deposits in a financial  institution with credit risk exposures in
excess of  statutory  FDIC  coverage.  The Company  has  incurred no losses as a
result of any of these unsecured situations.


Note F - Inventory

     As of September  30, 2004 and 2003,  inventory  consisted of the  following
components:

                               September 30,    September 30,
                                  2004               2003
                               -------------    -------------

         Raw materials           $   231,456      $   205,818
         Work in process             515,622          246,477
         Finished goods              278,746          198,802
                                 -----------      -----------

         Totals                  $ 1,025,824      $   651,097
                                 ===========      ===========




                (Remainder of this page left blank intentionally)



                                                                              11





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note G - Property and Equipment

Property and equipment consist of the following components:

                                    September 30,    September 30,    Estimated
                                        2004             2003        useful life
                                    -------------- ---------------   -----------

   Manufacturing equipment          $   7,623,415     $  6,895,850    3-10 years
   Office furniture and fixtures           82,719           62,893     3-7 years
   Leasehold improvements                 187,397          190,028    8-20 years
                                    -------------     ------------
                                        7,893,531        7,148,771
   Accumulated depreciation            (4,595,887)      (3,891,321)
                                    -------------     ------------

   Net property and equipment       $   3,297,644     $  3,257,450
                                    =============     ============

     Total  depreciation  expense  charged to operations for the respective nine
month periods ended September 30, 2004 and 2003 was  approximately  $529,496 and
$498,020.

     Included in the amounts reflected in the accompanying balance sheet are the
following fixed assets on long-term capital leases:

                                            September 30,    September 30,
                                                2004               2003
                                            -------------    -------------

     Manufacturing equipment                 $   153,400      $   153,400
     Less accumulated depreciation               (81,364)         (66,024)
                                             -----------      -----------
                                             $    72,036      $    87,376
                                             ===========      ===========


Note H - Working Capital Advance

     On March  13,  2003,  La Jolla  Cove  Investors,  Inc.,  the  holder of the
Company's convertible debenture, advanced the Company an additional $200,000 for
working capital purposes. At La Jolla Cove's sole discretion, the $200,000 could
be allocated in any proportion to a) an increase in the principal  amount of the
debenture and/or b) a prepayment for a future warrant  exercise.  During the 2nd
quarter of 2003, La Jolla  elected to add this balance to the principal  balance
on the convertible debenture.

     In August 2004, the Company's controlling shareholders advanced the Company
approximately  $74,000 for working  capital to fund  certain  capital  equipment
purchases.  These  advances  are  non-interest  bearing and are  repayable  upon
demand.




                (Remainder of this page left blank intentionally)



                                                                              12





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note I- Capital Leases Payable

     Capital  leases  payable  consist of the following as of September 30, 2004
and 2003, respectively:



                                                                  September 30, September 30,
                                                                    2004            2003
                                                                  ------------- -------------
                                                                                    
Three  capital  leases,  respectively,  payable  to  various
equipment  financing  companies.  Interest  ranging  between
11.37% and 14.05%. Payable in aggregate monthly installments
of approximately  $935,  including accrued  interest.  Final
maturities  occur between  September 2004 and December 2004.
Collateralized  by  the  underlying   leased   manufacturing
equipment.                                                         $     525    $  10,335

     Less current maturities                                            (525)      (9,507)
                                                                   ---------    ---------
     Long-term portion                                             $       -    $     828
                                                                   =========    =========


Future maturities of capital leases payable are as follows:

                   Year ending
                   December 31      Amount
                   ------------------------

                    2004            $ 2,606
                                    =======

Note J - Convertible Debenture

     On  October 4,  2002,  the  Company  issued an 8.0%  Convertible  Debenture
(Debenture)  in the face amount of $250,000  and a Warrant  which  requires  the
Holder to purchase  shares of common stock equal to ten (10) times the number of
shares of common stock issued to the Holder on conversion of the  Debenture.  In
no event shall the number of shares issued under the Warrant exceed 30,000,000.

     During the second quarter of Calendar 2003, the Holder made additional cash
advances  to the  Company  totaling  $350,000  which  were  applied  to the then
outstanding principal balance on the Debenture.

     The Debenture  bears  interest at 8.0% and matures on October 4, 2004.  The
full  principal  amount of the Debenture is due upon default,  as defined in the
Debenture  agreement.  The  Debenture  interest  is  payable  monthly in arrears
commencing on November 15, 2002.

     At June 30, 2004 and 2003,  respectively,  the  outstanding  balance on the
Debenture was approximately $266,365 and $524,865.

     In  December  2002,  the  Company  and the  Debenture  Holder  amended  the
above-referenced debenture and warrants as follows:

          The number of common  shares into which the debenture may be converted
     is equal to the dollar amount of the debenture being  converted  multiplied
     by eleven,  minus the product of the  conversion  price,  multiplied by ten
     times the dollar amount of the debenture  being  converted,  divided by the
     conversion  price.  The  conversion  price is obtained by  multiplying  the
     average of the five (5) lowest Volume Weighted Average Prices (VWAP) during
     the 20  trading  days  prior  to the  date of  conversion  by the  Discount
     Multiplier of 80%.


                                                                              13





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note J - Convertible Debenture - Continued

     The warrants are exercisable at $1.00 per share for up to 2,500,000 shares.
     The warrant holder is obligated to exercise the warrant  concurrently  with
     the  conversion  of the debenture for a number of shares equal to ten times
     the dollar amount of the debenture being converted.

     The  Company  was  obligated  to file a  Registration  Statement  under the
Securities  Act of 1933 to register the underlying  conversion  shares on either
Form SB-2 or S-3. This Registration  Statement was declared  effective by the U.
S. Securities and Exchange Commission on May 14, 2003.

     The Debenture Holder has  contractually  committed to convert not less than
5.0% and not more than 10.0% of the original face value of the Debenture monthly
beginning the month after the effective date of the  Registration  Statement and
the Holder is required to concurrently  exercise warrants and purchase shares of
common stock equal to ten (10) times the number of shares of common stock issued
to the Holder upon the respective mandatory conversion of the Debenture.

     The Holder has  further  contractually  agreed to  restrict  its ability to
convert the  Debenture  or exercise  their  warrants  and receive  shares of the
Company's common stock such that the number of shares held by the Holder and its
affiliates  after such  conversion or exercise does not exceed 4.99% of the then
issued and outstanding shares of common stock of the Company.

     In the event an election to convert is made and the volume weighted average
price of the Company's  common stock is below $0.30 per share, the Company shall
have the right to prepay  any  portion  of the  outstanding  Debenture  that was
elected to be converted, plus any accrued and unpaid interest, at 125.0%.

     Due to the contractually agreed mandatory conversion of this Debenture, the
Company has  reflected  this  transaction  in its balance sheet as a "mezzanine"
level debt  obligation on its balance  sheet,  between "Total  Liabilities"  and
"Stockholders'  Equity". Upon the respective mandatory  conversion,  the Company
will  relieve  the  respective  portion  of the  Debenture  and the any  related
accrued,  but unpaid interest,  and credit this amount to the respective "common
stock" and "additional  paid-in capital"  accounts in the  stockholder's  equity
section for the par value and excess amount over the par value of the respective
shares issued.

     As  the  warrant  is   non-detachable   from  the  Debenture  and  requires
simultaneous exercise upon conversion of the Debenture, no value was assigned to
the issued  warrant.  Upon exercise of the warrant,  the Company will record the
issuance of the underlying  shares as a new issuance of common stock on the date
of each respective exercise.

     On various dates through June 30, 2004,  the  Debenture  Holder  elected to
convert an aggregate $333,635, through 29 separate transactions,  in outstanding
Debenture  principal into restricted,  unregistered  common stock. This election
caused the Company to issue 8,711,753 shares of restricted,  unregistered common
stock to the Debenture Holder. Additionally, pursuant to the contract terms, the
Debenture Holder concurrently  exercised a portion of the outstanding Warrant to
purchase 3,336,350 shares of the Company's restricted, unregistered common stock
for gross proceeds of $3,336,350.

     As of June 30, 2004, pursuant to the conversion terms of the Debenture, the
Debenture Holder is in arrears in the contractually  obligated conversions,  and
accordingly,  the related  mandatory  warrant  exercise  and owes the Company an
aggregate  $275,000  in cash  for  Warrant  exercise  and  debenture  conversion
transactions.



                                                                              14





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note K - Preferred Stock Transactions

     Preferred  stock  consists of the  following as of  September  30, 2004 and
2003, respectively:



                                              September 30, 2004      September 30, 2003
                                              ------------------      ------------------
                                              # shares   value       # shares    value
                                              -------- ---------     --------  ---------
                                                                         
Series A Cumulative Convertible Stock           12,000 $  60,000       32,000  $ 160,000
Series B Cumulative Convertible Stock           91,700   458,500       91,700    458,500
                                              -------- ---------     --------  ---------
                                               103,700   518,500      123,700    618,500
                                                       =========               =========
Beneficial Conversion Feature Discount                                           (15,890)
                                                       ---------               ---------

     Totals                                              518,500               $ 602,610
                                                       =========               =========


     In  September,  October and  November  2001,  the Company sold an aggregate
222,600 shares of $5.00 Series A Convertible Preferred Stock (Series A Preferred
Stock)  for  total  proceeds  of  approximately  $1,113,000  through  a  Private
Placement  Memorandum.  The Series A Convertible  Preferred  Stock  provides for
cumulative  dividends at a rate of 8.0% per year, payable quarterly,  in cash or
shares of the Company's  common stock at the Company's  election.  Each share of
Series A Preferred Stock is convertible  into 11 shares of the Company's  common
stock initially at any time after 6 months of the date of issue and prior to the
notice of redemption  at the option of the holder,  subject to  adjustments  for
customary  anti-dilution events. In December 2001, at the request of the holders
of the Series A Preferred Stock, the Company and the individual holders modified
the holding period for conversion to allow for conversion in December 2001.

     In  September   2001,  the  Company's   principal   stockholder   converted
approximately  $4,007,327  of unsecured  debt and  approximately  $3,546,273  of
cumulative  and  unpaid  accrued  interest  into  1,510,710  shares  of Series A
Preferred Stock.

     In  September   2001,   a  creditor  of  the  Company   agreed  to  convert
approximately  $10,000 of trade  accounts  payable into 2,000 shares of Series A
Preferred Stock.

     In December  2001,  concurrent  with a  modification  in the holding period
prior to  conversion,  certain  holders of the Series A Preferred  Stock  orally
notified  the Company of their  intent to exercise  the  conversion  features on
1,749,720  issued  and  outstanding  shares of  Series A  Preferred  Stock  into
19,246,920  shares of common stock prior to December 31, 2001. Due to the timing
of  the  requisite  documentation,  the  clerical  activities  related  to  this
conversion were not completed until February 2002.

     In conjunction with the Series A Preferred Stock,  certain shares were sold
after the  Company's  common  stock was  approved  for  trading by the  National
Association of Securities Dealers on the OTC Bulletin Board in October 2001. The
shares  of  Series  A  Preferred  Stock  sold  subsequent  to this  date  had an
equivalent  per share value of common stock below the ending quoted market price
of the Company's common stock on their  respective issue dates.  This difference
created a Beneficial  Conversion  Feature Discount of approximately  $1,207,993.
This discount was then amortized over the unexpired time period between the date
of issue of the eligible  shares and the eligible  conversion  date, as amended.
All of the shares sold  subsequent to the initial trading date were converted in
December  2001  and,  accordingly,  the  approximate  $1,207,993  in  Beneficial
Conversion Feature Discount was fully amortized to operations.

     In December  2002,  a holder of 5,000  shares of Series A  Preferred  Stock
exercised his conversion rights and converted these shares of Series A Preferred
Stock into 55,000 shares of restricted, unregistered common stock.


                                                                              15





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note K - Preferred Stock Transactions - Continued

     In  January  2003,  three  separate  holders  of 9,000  shares  of Series A
Preferred Stock exercised their conversion  rights and converted these shares of
Series A Preferred stock into 99,000 shares of restricted,  unregistered  common
stock.

     In May 2003, the Company sold an aggregate  91,700 shares of $5.00 Series B
Convertible  Preferred  Stock (Series B Preferred  Stock) for total  proceeds of
approximately  $458,500 through a separate  Private  Placement  Memorandum.  The
Series B Convertible Preferred Stock provides for cumulative dividends at a rate
of 8.0% per year, payable  quarterly,  in cash or shares of the Company's common
stock at the  Company's  election.  Each  share of Series B  Preferred  Stock is
convertible  into 11 shares of the Company's  common stock initially at any time
after 6 months of the date of issue and prior to the notice of redemption at the
option of the holder, subject to adjustments for customary anti-dilution events.


Note L - Common Stock Transactions

     In  January  2003,  the  Company  issued  an  aggregate  937,568  shares of
restricted,  unregistered  common  stock  for  cash  proceeds  of  approximately
$324,182.  These sales were made at a price of either  $0.23 or $0.36 per share,
which was in excess of the discounted "fair value" of the Company's common stock
based on the quoted  closing price of the Company's  common stock on the date of
the  respective  transaction.  The  proceeds of this  transaction  were used for
operating  working  capital.  The  Company  relied  upon  Section  4(2)  of  the
Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in this transaction.

     In  February  2003,  the  Company  issued  384,615  shares  of  restricted,
unregistered  common stock for cash proceeds of  approximately  $100,000.  These
sales  were  made at a price of $0.26  per  share,  which  was in  excess of the
discounted  "fair  value" of the  Company's  common  stock  based on the  quoted
closing  price of the  Company's  common  stock  on the  date of the  respective
transaction.  The proceeds of this transaction were used to reduce the Company's
outstanding  long-term  debt.  The  Company  relied  upon  Section  4(2)  of the
Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in this transaction.

     In  March  2003,   the  Company   issued   972,222  shares  of  restricted,
unregistered  common stock for cash proceeds of  approximately  $350,000.  These
sales  were  made at a price of $0.36  per  share,  which  was in  excess of the
discounted  "fair  value" of the  Company's  common  stock  based on the  quoted
closing  price of the  Company's  common  stock  on the  date of the  respective
transaction.  The proceeds of this transaction were used to reduce the Company's
outstanding  long-term  debt.  The  Company  relied  upon  Section  4(2)  of the
Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in this transaction.

     In  March  2003,  the  Company  issued  an  aggregate   966,608  shares  of
restricted,  unregistered  common  stock to the  Holder  of the  Company's  8.0%
Convertible  Debenture  upon  notice of  conversion  of $35,000  of  outstanding
principal  and  exercise  of a portion of the  outstanding  warrant to  purchase
350,000  shares of common stock.  This  transaction  was valued at $385,000,  or
approximately  $0.40 per  share,  which was in  excess of the  discounted  "fair
value" of the  Company's  common stock based on the quoted  closing price of the
Company's  common  stock on the  date of the  respective  transaction.  The cash
proceeds of this  transaction  were used to provide  working capital and support
operations.


                                                                              16





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note L - Common Stock Transactions - Continued

     In May 2003, the Company  issued 1,967 shares of  restricted,  unregistered
common stock in payment of approximately  $1,200 in accrued dividends payable on
the Company's  outstanding  Series A Preferred Stock for the quarter ended March
31, 2003. The Company relied upon Section 4(2) of the Securities Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.

     During the period from July 1, 2003 through September 30, 2003, the Company
issued  an  aggregate   2,902,129   shares  of  common  stock,  in  15  separate
transactions,  in  exchange  for the  redemption  of  approximately  $93,500  in
outstanding  debenture  balance  and  approximately  $935,000  in cash  from the
exercise of the  affiliated  warrant.  Where the closing  price of the Company's
common stock was in excess of the  respective  price per share on the respective
transaction   date,   the  Company   recognized  a  charge  to  operations   for
"compensation  expense  related  to common  stock  issuances  at less than "fair
value".  The cumulative effect of transactions  where the transaction  price, as
established in the Debenture  Agreement,  was less than the closing price on the
date  of  the  respective  transactions  resulted  in  a  cumulative  charge  to
operations of approximately $317,539 during this time period.

     In October  2003,  in a separate  transaction,  the Company sold  2,200,000
shares of restricted, unregistered common stock to the Debenture Holder for cash
proceeds of approximately  $400,000, or approximately $0.18 per share, which was
in excess of the discounted  "fair value" of the Company's common stock based on
the  quoted  closing  price  of the  Company's  common  stock on the date of the
respective  transaction.  The cash  proceeds  of this  transaction  were used to
provide working capital and support operations.

     In October 2003, the Company issued an aggregate 1,659,847 shares of common
stock,  in  3  separate   transactions,   in  exchange  for  the  redemption  of
approximately   $40,000  in  outstanding  debenture  balance  and  approximately
$400,000 in cash from the exercise of the affiliated warrant.  Where the closing
price of the Company's  common stock was in excess of the  respective  price per
share on the respective  transaction  date,  the Company  recognized a charge to
operations for  "compensation  expense related to common stock issuances at less
than "fair value".  The cumulative effect of transactions  where the transaction
price,  as  established  in the Debenture  Agreement,  was less than the closing
price on the date of the respective transactions resulted in a cumulative charge
to operations of approximately $146,189 during this time period.

     In  October  2003,  the  Company  issued  an  aggregate  37,866  shares  of
restricted,  unregistered  common stock in payment of  approximately  $16,710 in
accrued  dividends  payable on the Company's  outstanding  Series A and Series B
Preferred  Stock for the quarters  ended June 30, 2003 and  September  30, 2003,
collectively.  The Company  relied upon  Section 4(2) of the  Securities  Act of
1933,  as amended,  for an exemption  from  registration  of these shares and no
underwriter was used in this transaction.

     In  January  2004,   the  Company   issued  38,038  shares  of  restricted,
unregistered  common  stock in  payment  of  approximately  $10,000  in  accrued
dividends payable on the Company's  outstanding  Series A and Series B Preferred
Stock for the quarter ended  December 31, 2003.  The Company relied upon Section
4(2)  of  the  Securities  Act of  1933,  as  amended,  for  an  exemption  from
registration of these shares and no underwriter was used in this transaction.



                (Remainder of this page left blank intentionally)


                                                                              17





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note L - Common Stock Transactions - Continued

     During the period from January 1, 2004 through March 31, 2004,  the Company
issued  an  aggregate  2,400,000  shares of common  stock,  in two (2)  separate
transactions,  in  exchange  for the  redemption  of  approximately  $50,000  in
outstanding  debenture  balance  and  approximately  $500,000  in cash  from the
exercise of the  affiliated  warrant.  Where the closing  price of the Company's
common stock was in excess of the  respective  price per share on the respective
transaction   date,   the  Company   recognized  a  charge  to  operations   for
"compensation  expense  related  to common  stock  issuances  at less than "fair
value".  The cumulative effect of transactions  where the transaction  price, as
established in the Debenture  Agreement,  was less than the closing price on the
date  of  the  respective  transactions  resulted  in  a  cumulative  charge  to
operations of approximately $321,000 during this time period.

     In May 2004, the Company  issued 25,260 shares of restricted,  unregistered
common stock in payment of approximately  $9,170 in accrued dividends payable on
the Company's  outstanding  Series B Preferred Stock for the quarter ended March
31, 2004. The Company relied upon Section 4(2) of the Securities Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.

     During the period from April 1, 2004  through  June 30,  2004,  the Company
issued an  aggregate  3,000,000  shares of common  stock,  in three (3) separate
transactions,  in  exchange  for the  redemption  of  approximately  $75,000  in
outstanding  debenture  balance  and  approximately  $750,000  in cash  from the
exercise of the  affiliated  warrant.  Where the closing  price of the Company's
common stock was in excess of the  respective  price per share on the respective
transaction   date,   the  Company   recognized  a  charge  to  operations   for
"compensation  expense  related  to common  stock  issuances  at less than "fair
value".  The cumulative effect of transactions  where the transaction  price, as
established in the Debenture  Agreement,  was less than the closing price on the
date  of  the  respective  transactions  resulted  in  a  cumulative  charge  to
operations of approximately  $35,000 during this time period.  Additionally,  on
June 29, 2004, the Company issued an additional 1,000,000 shares of common stock
in advance of the exercise of a $25,000 redemption on the outstanding  debenture
payable and a $250,000 cash payment on the exercise of the  affiliated  warrant,
which was received in July 2004.

     On  May  26,  2004,  the  Company  issued  300,000  shares  of  restricted,
unregistered  common  stock to two  separate  corporations  in payment  and full
satisfaction  of all amounts due for fees and/or  commissions due in conjunction
with the Company's convertible debenture financing transaction. This transaction
was valued at approximately  $36,000, which approximated the "fair value" of the
underlying  securities given in payment and the related charges for the services
provided. The Company relied upon Section 4(2) of the Securities Act of 1933, as
amended,  for an exemption from  registration of these shares and no underwriter
was used in this transaction.

     In  August  2004,   the  Company   issued  29,746  shares  of   restricted,
unregistered  common  stock  in  payment  of  approximately  $9,170  in  accrued
dividends payable on the Company's  outstanding Series B Preferred Stock for the
quarter  ended June 30,  2004.  The  Company  relied  upon  Section  4(2) of the
Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in this transaction.


Note M - Rental Commitments

     The Company leases its corporate office and manufacturing facility from its
controlling stockholder under a long- term operating lease agreement.  The lease
requires a monthly payment of approximately  $5,410,  including applicable sales
taxes.  After the five (5) year and five  month term of this  lease,  should the
parties  desire to renew this lease,  Lessor and Lessee  shall  renegotiate  the
annual rent paid by Lessee.  The Company is  responsible  for all  utilities and
maintenance expenses. The lease expires on December 31, 2009. Total rent expense
under this lease was approximately $67,075 and $54,100,  respectively,  for each
of the years ended December 31, 2003 and 2002.


                                                                              18





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note M - Rental Commitments - Continued

     The Company's subsidiary,  IPE, leases it's manufacturing  facility from an
unrelated third-party under a long-term operating lease agreement. This lease is
for a period of five (5) years and requires graduated monthly payments, changing
on the lease anniversary date, ranging from approximately $1,751 to $1,914, plus
the applicable  sales taxes.  The Company is  responsible  for all utilities and
maintenance expenses.  The lease expires on February 28, 2007 and may be renewed
for an additional five (5) year term at a rental rate of  approximately  $1,971,
plus applicable sales taxes for the first renewal year and 3.0% increase on each
succeeding   anniversary   date.   Total  rent  expense  under  this  lease  was
approximately  $20,752 and  $16,622,  respectively,  for each of the years ended
December 31, 2003 and 2002.

     In May 2004,  the Company  entered into a long-term  lease  agreement for a
warehouse  facility  adjacent to the Company's  primary office and manufacturing
facility.  This lease is for a period of two (2) years and requires  payments of
approximately  $6,206 per month for the first 12 months and approximately $6,393
for  the  second  12  months,  plus  applicable  sales  taxes.  The  Company  is
responsible  for all utilities and maintenance  expenses.  This lease expires on
May 31, 2006.  Further,  the Company is  responsible  for any  incremental  real
estate  taxes and property  insurance  in excess of the amounts  incurred by the
landlord for the calendar year immediately preceding the execution of the lease.

     Future minimum rental payments on the above leases are as follows:

                        Year ended
                        December 31,  Amount  
                        ----------------------
                        2004         $ 138,365
                        2005           166,974
                        2006           117,244
                        2007            72,643
                        2008            68,815
                        2007            68,815
                                     ---------

                        Totals       $ 632,856
                                     =========

Note N - Income Taxes

     The  components of income tax (benefit)  expense for the nine month periods
ended September 30, 2004 and 2003, respectively, are as follows:

                                Nine months     Nine months
                                  ended           ended
                                September 30,   September 30,
                                   2004            2003
                                -------------   -------------
       Federal:
         Current                $     -           $     -
         Deferred                     -                 -
                                -------           -------
                                      -                 -
                                -------           -------
       State:
         Current                      -                 -
         Deferred                     -                 -
                                -------           -------
                                      -                 -
                                -------           -------
         Total                  $     -           $     -
                                =======           =======


                                                                              19





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note N - Income Taxes - Continued

     As of December 31, 2003, the Company has a net operating loss  carryforward
of approximately  $8,500,000 to offset future taxable income. Subject to current
regulations, components of this carryforward began to expire in 2003. The amount
and  availability  of the net  operating  loss  carryforwards  may be subject to
limitations set forth by the Internal  Revenue Code.  Factors such as the number
of shares ultimately issued within a three year look-back period;  whether there
is a deemed more than 50 percent change in control; the applicable long-term tax
exempt bond rate;  continuity of historical  business;  and subsequent income of
the  Company  all  enter  into  the  annual   computation  of  allowable  annual
utilization of the carryforwards.

     The Company's income tax expense (benefit) for the nine month periods ended
September 30, 2004 and 2003,  respectively,  differed from the statutory federal
rate of 34 percent as follows:

                                                      Nine months  Nine months
                                                         ended         ended
                                                     September 30, September 30,
                                                         2004          2003
                                                     ---------------------------

Statutory rate applied to loss before income taxes     $ (799,000)  $  (902,000)
Increase (decrease) in income taxes resulting from:
     State income taxes                                         -             -
     Other, including reserve for deferred tax asset      799,000       902,000
                                                       ----------   -----------

       Income tax expense                              $        -   $         -
                                                       ==========   ===========

     Temporary differences, consisting primarily of statutory differences in the
depreciable  lives for property and equipment,  between the financial  statement
carrying  amounts and tax bases of assets and liabilities  give rise to deferred
tax assets and liabilities as of December 31, 2004 and 2003, respectively:

                                                   December 31,   December 31,
                                                       2004            2003
                                                  ------------------------------

     Deferred tax assets - long-term - net        $   3,000,000   $   2,150,000
     Less valuation allowance                        (3,000,000)     (2,150,000)
                                                  -------------   -------------

       Net Deferred Tax Asset                     $           -   $           -
                                                  =============   =============

     During  the years  ended  December  31,  2004 and 2003,  respectively,  the
valuation allowance increased by approximately $656,000 and $629,000.


Note O - Subsequent Events

     In  October  2004,   the  Company   issued  53,908  shares  of  restricted,
unregistered  common  stock  in  payment  of  approximately  $9,170  in  accrued
dividends payable on the Company's  outstanding Series B Preferred Stock for the
quarter ended  September 30, 2004.  The Company  relied upon Section 4(2) of the
Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in this transaction.



                                                                              20





                   American Ammunition, Inc. and Subsidiaries

             Notes to Consolidated Financial Statements - Continued


Note O - Subsequent Events - Continued

     On October 19, 2004, the Company completed negotiations and closed an Asset
Purchase  Agreement by and between the Company,  Voluto Ventures LLC (a New York
limited  liability  company  and Voluto  Patent  Holding  Co.,  Inc. (a New York
corporation).  The Company acquired certain  machinery and equipment,  inventory
and the assignment of certain patents and  intellectual  property related to the
manufacture  and  production of specialty  small- arms  ammunition.  The Company
issued 1,111,111 shares of restricted, unregistered common stock with an agreed-
upon value of $500,000 for this transaction.

     The sellers  agreed to  contractually  restrict their sale of the 1,111,111
shares of  restricted,  unregistered  common stock to an amount of up to 175,000
shares per month starting on April 28, 2005.


                (Remainder of this page left blank intentionally)



                                                                              21








Item 2 - Management's Discussion and Analysis or Plan of Operation

(1)  Caution Regarding Forward-Looking Information

     Certain  statements  contained in this Quarterly Report including,  without
limitation, statements containing the words "believes", "anticipates", "expects"
and  words  of  similar  import,  constitute  forward-looking  statements.  Such
forward-looking  statements  involve known and unknown risks,  uncertainties and
other factors that may cause the actual results,  performance or achievements of
the Company,  or industry  results,  to be materially  different from any future
results,   performance   or   achievements   expressed   or   implied   by  such
forward-looking statements.

     Such factors include, among others, the following: international,  national
and local  general  economic and market  conditions:  demographic  changes;  the
ability of the Company to sustain, manage or forecast its growth; the ability of
the Company to successfully make and integrate acquisitions;  raw material costs
and availability; new product development and introduction;  existing government
regulations  and  changes  in,  or  the  failure  to  comply  with,   government
regulations;  adverse publicity;  competition; the loss of significant customers
or suppliers;  fluctuations  and  difficulty in forecasting  operating  results;
changes in business strategy or development  plans;  business  disruptions;  the
ability  to attract  and  retain  qualified  personnel;  the  ability to protect
technology; and other factors referenced in this and previous filings.

     Given these  uncertainties,  readers of this Quarterly Report and investors
are cautioned not to place undue  reliance on such  forward-looking  statements.
The Company  disclaims any  obligation to update any such factors or to publicly
announce the result of any  revisions to any of the  forward-looking  statements
contained herein to reflect future events or developments.

Overview

     We were  incorporated  on  February 1, 2000 in the State of  California  as
FirsTelevision.com.  We  subsequently  changed our  corporate  name to FBI Fresh
Burgers International which unsuccessfully marketed a business plan concept of a
national "fast food" restaurant chain.

     American  Ammunition,   Inc.  is  a  holding  company  with  two  operating
subsidiaries: F&F Equipment, Inc. and Industrial Plating Enterprise Co.

     F&F Equipment,  Inc. was  incorporated on October 4, 1983 under the laws of
the State of  Florida.  The  company  was  formed to engage  principally  in the
"import,  export,  retail & wholesale of firearms equipment,  ammunition & other
devices and for the purpose of transacting any and/or all lawful  business." F&F
conducts   its  business   operations   under  the  assumed  name  of  "American
Ammunition."




                                       22



     In June 2002, American  Ammunition,  Inc. formed a wholly owned subsidiary,
Industrial  Plating  Enterprise Co., which started  production on June 14, 2002.
Industrial   Plating  is  a  fully   licensed   and   approved   electrochemical
metallization  facility with  significant  capacity for  processing  our line of
projectiles   as  well  as  other   products   and  services   while   employing
environmentally sound water conservation and proven waste treatment techniques.

     During the third quarter of 2003, the Company's operations  experienced the
negative  impact of a lower than  anticipated  or budgeted  purchases  by Elliot
Brothers, a significant customer.

     However,  during this same time  period,  the  Company  has entered  into a
strategic alliance with Israel Military Industries (IMI), an entity owned by the
State of  Israel,  for the  cross-production  and  sale of  various  small  arms
ammunition. This alliance is anticipated to greatly expand the Company's catalog
of products and assist in utilizing existing production capacity.

     In prior periods,  the Company executed a private  labeling  agreement with
Century  International Arms, Inc. (Century).  Under this agreement,  the Company
was to produce it's standard catalog of small arms ammunition plus one specialty
small arms  cartridge to  Century's  specifications  for  packaging in Century's
designated  labeling.  This agreement required no modifications to the Company's
production  line and did not require the addition of  supplemental  personnel or
equipment.  The Company made an initial shipment under this agreement to Century
during  December  2003. In  early-January  2004, the Company began to experience
problems with Century  regarding  Century's  compliance  with their  performance
criteria  under  this  agreement.  During  the first  quarter  of 2004,  Century
defaulted on certain  agreed-upon  payment  schedules on merchandise sold during
December 2003. In repayment of the outstanding  trade debt, the Company accepted
unscheduled  product  returns as payment of the trade debt. As a result of these
issues, the Company  recognized a charge to operations of approximately  $28,000
on it's business activity with Century.  The returned merchandise was repackaged
and is resalable  by the Company to other  customers.  As of June 30, 2004,  the
Company has cancelled this agreement,  and is contemplating  litigation  against
Century for breach of contractual obligations under this agreement.

     Additionally,  the Company has been awarded  three (3)  separate  contracts
from  various  departments  of the U. S.  Government.  Each  contract  is for an
initial term of one year  (commencing  between  April 24, 2003 and September 30,
2003) with four (4) successive  individual  one-year extension options, of which
the first extension  period has been exercised.  The contracts are summarized as
follows:

Contract 1:    U. S. Department of State. Minimum annual volume of approximately
               100,000 rounds of military grade small arms  ammunition.  Maximum
               annual volume of approximately  5,000,000 rounds.  Maximum volume
               may be increased at the discretion of the Contracting Officer and
               respective  utilization  requirements.  The Company has  received



                                       23




               firm  orders  for  2,265,000  rounds  of  ammunition  under  this
               contract  and  has  approximately   1,265,000  rounds  ready  for
               shipment.  The ammunition  under this contract will be subject to
               the strategic alliance with Israel Military Industries (IWI).

Contract 2:    U. S.  Department  of  Energy.  This  contract  covers  seven (7)
               separate products in the Company's  standard catalog of products.
               The U. S.  Department  of  Energy is  obligated  to  purchase  an
               aggregate of 4,549,000 rounds of ammunition under this contract.

Contract 3:    U. S. Department of Homeland Security.  This contract covers four
               (4) separate  products being introduced to the Company's  catalog
               through  the   strategic   alliance  with  IMI  and  requires  no
               modifications to the Company's production facilities or additions
               to the labor force.  The minimum annual volume is 1,000 rounds of
               each product and a maximum  annual volume of 9,600,000  rounds of
               two  (2)  products  and  36,000,000  of  the  remaining  two  (2)
               products.

     The Company has received purchase orders against these contracts;  however,
due to delays in receiving the initial purchase orders and the  unpredictability
of  subsequent  reorder  cycles,  the Company is unable to fully  anticipate  or
predict the future impact of these contracts. The Company remains in negotiation
and to prepare bids on other  contracts from these and other U. S.  Governmental
agencies.

     During  the  first  quarter  of  2004,  the  Company   commenced  a  direct
solicitation  program for it's "dealer  direct" sales program.  As this endeavor
has  received  a very  positive  initial  response  from  the  qualified  retail
resellers  of the  Company's  product,  the  announcement  of this program had a
significantly  detrimental  impact on the Company's  relationship with wholesale
distributors  and,  accordingly,  had a  significant  negative  impact  on first
quarter 2004 sales.  The Company  continues to experience  increases in customer
demand,  order size and reorder  quantities  in this program by smaller  "single
store" owner/operators of retail outlets selling the Company's products.  During
November 2004, the Company  qualified it's 1,000th dealer under this program for
direct sales and it is anticipated  that the overall  Calendar 2004 sales volume
through the "dealer  direct"  program may well equal or exceed the sales volumes
generated by wholesale distributors in prior years.

Results of Operations

Nine months  ended  September  30,  2004  compared  with the nine  months  ended
September 30, 2003.

     During the nine and three months ended  September 30, 2004, we  experienced
net revenues of approximately $1,712,000 and $862,000, respectively, as compared
to  approximately  $1,216,000  and $317,000 for the same  respective  periods of
2003.



                                       24




     During  the  first  quarter  of  2004,  the  Company   commenced  a  direct
solicitation  program for it's "dealer  direct" sales program.  As this endeavor
has  received  a very  positive  initial  response  from  the  qualified  retail
resellers  of the  Company's  product,  the  announcement  of this program had a
significantly  detrimental  impact on the Company's  relationship with wholesale
distributors  and,  accordingly,  had a  significant  negative  impact  on first
quarter 2004 sales. The Company continues to experience significant increases in
customer  demand,  order size and reorder  quantities in this program by smaller
"single store" owner/operators of retail outlets selling the Company's products.

     During November 2004, the Company  qualified it's 1,000th dealer under this
program for direct sales and it is  anticipated  that the overall  Calendar 2004
sales volume  through the "dealer  direct"  program may well equal or exceed the
sales volumes generated by wholesale distributors in prior years.

     We experienced costs of goods sold of approximately $2,435,000 for the nine
months ended September 30, 2004 as compared to approximately  $2,209,000 for the
nine  months  ended   September   30,  2003.   Included  in  these  amounts  are
approximately $524,000 and $495,000,  respectively,  for depreciation expense on
manufacturing equipment and leasehold improvements on our production facility.

     Management is of the opinion that the production  labor force is stable and
able to  maintain  a  constant  standard  of  quality  for  future  periods.  We
experience variable costs in the area of material consumption and direct labor.

     These  depreciation  levels are  anticipated  to remain fairly  constant as
compared  to the first  quarter of 2004.  Management  has  placed on order,  and
placed initial deposits on, new manufacturing  equipment to automate the product
packaging process and to add new quality  assurance  equipment on the production
line. These commitments aggregate  approximately $450,000, of which the majority
has been expended through September 30, 2004.

     Management,  at this time,  does not  anticipate  any  further  significant
capital equipment acquisitions.

     Further,  the addition of the Industrial  Plating  Enterprise Co. equipment
during  2003  allows us to produce  certain  components  which  were  previously
outsourced to unrelated third parties.

     For the nine month periods ended September 30, 2004 and 2003, respectively,
we have  generated  a negative  gross  profit of  approximately  $(723,000),  or
(42.21%), and approximately $(993,000), or (81.66%).

     As previously reported,  our research during the second quarter of 2004 has
revealed  that the various  governmental  agencies  which have  issued  purchase
contracts to us either purchased large quantities during the last 60 days of the
Federal   Government's  year  ended  September  30,  2003  or  are  experiencing



                                       25




transitional  purchasing  problems or issues  surrounding the  reorganization of
various  agencies  into the  Department of Homeland  Security,  with the related
issues of Congressional appropriations for funding the necessary expenditures of
these  reorganized  agencies.  The  actions  of the third  quarter  proved  this
research to be correct and we received  several  purchase  order releases on our
contract with the Department of Homeland  Security.  The timing of Congressional
approval of the related appropriation bills to fund the various executive branch
departments  of the United States of America  continues to impact the timing and
release of purchase orders under our contracts as previously discussed.

     We continue  to  anticipate  that with the  fulfillment  of the  government
contracts discussed above,  continually expanding retail consumer demand for our
product line, lower production costs being experienced from internally generated
plating  activities  and  adequate  liquidity,  we will be  able to  generate  a
positive  gross profit in future  periods.  Further,  based on  production  cost
information  developed during the 4th quarter of 2002 and further refined during
2003,  management  has  developed a new model for the pricing of its products to
its customers. It is anticipated that this model will allow management to better
manage expense levels, control labor costs and maximize revenue opportunities.

     We had minimal costs allocated to research and development  expenses during
either of the quarters ended September 30, 2004 and 2003.

     Through  the  nine  months   ending   September   30,  2004,   we  expended
approximately  $368,000 in advertising  and marketing  expenses,  principally in
developing  and promoting our retail  dealer  direct  program.  We anticipate to
continue our  marketing  efforts in this area in future  periods;  however,  the
volume and frequency of our expenditures  may fluctuate as management  allocates
available capital to these efforts.

     Other  general  and  administrative  expenses  increased  by  approximately
$57,000 from approximately $789,000 for the nine months ended September 30, 2003
as compared to  approximately  $846,000 for the nine months ended  September 30,
2004. These increases are not identifiable by one specific area; however, relate
to general corporate expenses,  office and administrative wages and salaries and
other related office overhead.

     Included in our results of operations for the first nine months of 2004 are
certain non-cash expenditure charges to operations of approximately $356,000 for
compensation  expense  related  to common  stock  issuances  at less than  "fair
value".  The  calculation  of these charges result from our issuing common stock
for either cash or services at valuations  below the closing quoted market price



                                       26




of our common stock (as discounted,  as applicable) and either the cash received
or the value of the services  provided to us by third parties.  During  Calendar
2003, we experienced a charge of  approximately  $94,000 for the amortization of
the Beneficial  Conversion  Feature Discount on our Preferred Stock. This charge
results  from the  difference  between the closing  quoted  market  price on our
common stock and the  equivalent  converted  price of our Mandatory  Convertible
Preferred Stock which was sold and converted during 2003.

     We recognized a net loss of approximately $(2,350,000) and $(2,662,000) for
the  respective   three  month  periods  ended  September  30,  2004  and  2003,
respectively, or $(0.03) and $(0.04) per share.

Liquidity And Capital Resources

     As of  September  30,  2004,  December  31, 2003 and  September  30,  2003,
respectively,  we had working capital of approximately $960,000,  $2,000,000 and
$1,348,000.  Our  working  capital  position  continues  to  fluctuate  based on
collections  on our  trade  accounts  receivable  and  receipt  of cash from the
mandatory  exercise  of  our  outstanding  warrant  contractually  tied  to  our
convertible debenture.  Further, we anticipate that we have sufficient inventory
levels to  support  our  retail  dealer  direct  program  and our  existing  and
anticipated U. S. Government contracts.

     We have used cash in operating  activities of approximately  $(727,500) and
$(1,901,000)   during  the  quarters   ended   September   30,  2004  and  2003,
respectively.

     The most significant use of cash in operations during the nine months ended
September  30,  2004 was for the  support  of our  operations  where our  costs,
expenses  and  overhead  was in excess of the sales  volume  that we  generated,
including  increased  advertising  and  marketing  expenses to institute our new
retail dealer direct program.

     We anticipate that our improved liquidity position will continue to improve
as  management  is of the opinion  that the  production  capacity is in place to
support all existing orders and accept existing  inquiries which have previously
been denied due to the lack of production capacity and liquidity.

     During the nine months ended September 30, 2004 and 2003, respectively,  we
added approximately  $436,000 and $59,000 in new equipment.  Depending on future
demand  for our  products,  we may  develop  plans to  increase  our  production
capacity by an additional  50% to 100%, as  influenced  by the  availability  of
manufacturing equipment on the open market and product sales demand.  Management
is of the opinion that  sufficient  demand will be present,  as supported by new
product  development and increased  product marketing  efforts,  to justify this
expansion.  However,  we may not be able to obtain  additional  funding or, that
such funding, if available, will be obtained on terms favorable to or affordable
by us.



                                       27




Convertible Debenture

     On October 4, 2002, we signed a Securities Purchase Agreement with La Jolla
Cove  Investors,  Inc.  (La  Jolla) for the sale of a  $250,000  8%  convertible
debenture  and a warrant to purchase up  30,000,000  shares of our common stock.
The  debenture  bears  interest  at 8% and  matures  two years  from the date of
issuance.

     In December  2002, the Company and La Jolla,  the Debenture  and/or Warrant
Holder, amended the above-referenced debenture and warrants as follows:

     The number of common  shares into which the  debenture  may be converted is
     equal to the dollar amount of the debenture being  converted  multiplied by
     eleven, minus the product of the conversion price,  multiplied by ten times
     the  dollar  amount  of  the  debenture  being  converted,  divided  by the
     conversion  price.  The  conversion  price is obtained by  multiplying  the
     average of the five (5) lowest Volume Weighted Average Prices (VWAP) during
     the 20  trading  days  prior  to the  date of  conversion  by the  Discount
     Multiplier of 80%.

     The warrants are exercisable at $1.00 per share for up to 2,500,000 shares.
     The Warrant Holder is obligated to exercise the warrant  concurrently  with
     the  conversion  of the debenture for a number of shares equal to ten times
     the dollar amount of the debenture being converted.

     We were obligated to file a Registration Statement under the Securities Act
of 1933 to register the underlying  conversion shares on either Form SB-2 or S-3
and have said  Registration  Statement  effective  no later  than 120 days after
October 4, 2002. Our Registration Statement on Form SB-2 was deemed effective by
the U. S. Securities and Exchange Commission on May 14, 2003 at 1:00 pm EDT.

     La Jolla has contractually  committed to convert not less than 5.0% and not
more than 10.0% of the original  face value of the Debenture  monthly  beginning
the month after the effective date of the Registration Statement and is required
to concurrently  exercise  warrants and purchase shares of common stock equal to
ten (10) times the number of shares of common  stock issued to La Jolla upon the
respective mandatory conversion of the Debenture.

     La Jolla has  further  contractually  agreed to  restrict  its  ability  to
convert the  Debenture  or exercise  their  warrants  and receive  shares of our
common stock such that the number of shares held them or their  affiliates after
such  conversion  or  exercise  does not  exceed  4.99% of the then  issued  and
outstanding shares of our common stock.

     In the event an election to convert is made and the volume weighted average
price of our common stock is below $0.30 per share,  we have the right to prepay
any portion of the outstanding Debenture that was elected to be converted,  plus
any accrued and unpaid interest, at 125.0%.



                                       28




     La Jolla could have  demanded  repayment of the  Debenture of 125.0% of the
face amount  outstanding,  plus all accrued and unpaid interest,  in cash at any
time prior to May 14,  2003,  the date that  underlying  Registration  Statement
under the Securities Act of 1933 was declared  effective by the U. S. Securities
and Exchange Commission, within 3 business days of such demand. If the repayment
was  accelerated,  we were  obligated to issue La Jolla 25,000  shares of common
stock and $10,000 cash for each 30 day period, or portion thereof,  during which
the face  amount,  including  interest  thereon,  remains  unpaid  with the cash
payment to increase to $15,000 for each 30 day period the balance remains unpaid
after the initial 90 day period.

     If La Jolla does not elect to accelerate the  Debenture,  the Company shall
immediately  issue and pay La Jolla  25,000  shares of common  stock and $10,000
cash for each 30 day period,  or portion thereof,  during which the face amount,
including interest thereon,  remains unpaid with the cash payment to increase to
$15,000 for each 30 day period the balance  remains  unpaid after the initial 90
day period.

     Due to the contractually agreed mandatory conversion of this Debenture,  we
have reflected this transaction in our balance sheet as a "mezzanine" level debt
obligation on its balance sheet,  between "Total Liabilities" and "Stockholders'
Equity".  Upon  the  respective  mandatory  conversion,   we  will  relieve  the
respective  portion of the  Debenture  and the any related  accrued,  but unpaid
interest,   and  credit  this  amount  to  the  respective  "common  stock"  and
"additional  paid-in capital" accounts in the  stockholder's  equity section for
the par value and  excess  amount  over the par value of the  respective  shares
issued.

     As  the  warrant  is   non-detachable   from  the  Debenture  and  requires
simultaneous exercise upon conversion of the Debenture, no value was assigned to
the issued  warrant.  Upon exercise of the warrant,  the Company will record the
issuance of the underlying  shares as a new issuance of common stock on the date
of each respective exercise.

     Concurrent  with the execution of the Debenture  agreement,  we executed an
engagement letter with La Jolla's counsel for legal  representation  with regard
to the  preparation of the  Registration  Statement  under the Securities Act of
1933 on Form SB-2.

     On March 13,  2003 and May 6, 2003,  La Jolla  Cove  Investors,  Inc.,  the
holder  of  the  Company's  convertible  debenture,   advanced  the  Company  an
additional  $200,000 and $150,000,  respectively,  for working capital purposes.
During  the second  quarter of 2003,  La Jolla  elected to  allocate  the entire
$350,000  in  additional  funding to the  principal  balance of the  convertible
debenture.



                                       29




     On various dates between May 7, 2003 and June 30, 2003, La Jolla elected to
convert  an  aggregate  $75,135,  through  six  (6)  separate  transactions,  in
outstanding Debenture principal into restricted, unregistered common stock. This
election   caused  the  Company  to  issue   1,334,777   shares  of  restricted,
unregistered common stock to the Debenture Holder. Additionally, pursuant to the
contract terms,  the Debenture  Holder  concurrently  exercised a portion of the
outstanding  Warrant to purchase  751,350  shares of the  Company's  restricted,
unregistered common stock for gross proceeds of $751,350.

     During the period from July 1, 2003 through September 30, 2003, the Company
issued  an  aggregate   2,902,129   shares  of  common  stock,  in  15  separate
transactions,  to La Jolla  in  exchange  for the  redemption  of  approximately
$93,500 in outstanding debenture balance and approximately $935,000 in cash from
the exercise of the affiliated warrant. Where the closing price of the Company's
common stock was in excess of the  respective  price per share on the respective
transaction   date,   the  Company   recognized  a  charge  to  operations   for
"compensation  expense  related  to common  stock  issuances  at less than "fair
value".  The cumulative effect of transactions  where the transaction  price, as
established in the Debenture  Agreement,  was less than the closing price on the
date  of  the  respective  transactions  resulted  in  a  cumulative  charge  to
operations of approximately $317,539 during this time period.

     In October 2003, the Company issued an aggregate 1,659,847 shares of common
stock,  in  3  separate   transactions,   in  exchange  for  the  redemption  of
approximately   $40,000  in  outstanding  debenture  balance  and  approximately
$400,000 in cash from the exercise of the affiliated warrant.  Where the closing
price of the Company's  common stock was in excess of the  respective  price per
share on the respective  transaction  date,  the Company  recognized a charge to
operations for  "compensation  expense related to common stock issuances at less
than "fair value".  The cumulative effect of transactions  where the transaction
price,  as  established  in the Debenture  Agreement,  was less than the closing
price on the date of the respective transactions resulted in a cumulative charge
to operations of approximately $146,189 during this time period.

     During the period from January 1, 2004 through March 31, 2004,  the Company
issued  an  aggregate  2,400,000  shares of common  stock,  in two (2)  separate
transactions,  in  exchange  for the  redemption  of  approximately  $50,000  in
outstanding  debenture  balance  and  approximately  $500,000  in cash  from the
exercise of the  affiliated  warrant.  Where the closing  price of the Company's
common stock was in excess of the  respective  price per share on the respective
transaction   date,   the  Company   recognized  a  charge  to  operations   for
"compensation  expense  related  to common  stock  issuances  at less than "fair
value".  The cumulative effect of transactions  where the transaction  price, as
established in the Debenture  Agreement,  was less than the closing price on the
date  of  the  respective  transactions  resulted  in  a  cumulative  charge  to
operations of approximately $321,000 during this time period.



                                       30




     During the period from April 1, 2004  through  June 30,  2004,  the Company
issued an  aggregate  3,000,000  shares of common  stock,  in three (3) separate
transactions,  in  exchange  for the  redemption  of  approximately  $75,000  in
outstanding  debenture  balance  and  approximately  $750,000  in cash  from the
exercise of the  affiliated  warrant.  Where the closing  price of the Company's
common stock was in excess of the  respective  price per share on the respective
transaction   date,   the  Company   recognized  a  charge  to  operations   for
"compensation  expense  related  to common  stock  issuances  at less than "fair
value".  The cumulative effect of transactions  where the transaction  price, as
established in the Debenture  Agreement,  was less than the closing price on the
date  of  the  respective  transactions  resulted  in  a  cumulative  charge  to
operations of approximately  $35,000 during this time period.  Additionally,  on
June 29, 2004, the Company issued an additional 1,000,000 shares of common stock
in advance of the exercise of a $25,000 redemption on the outstanding  debenture
payable and a $250,000 cash payment on the exercise of the  affiliated  warrant,
which was received in July 2004.

Research and Development

     Depending  on the demand for new product  lines and the  refinement  of our
production  processes  under  our  production  agreement  with  Israel  Military
Industries   (IMI),   an  entity   owned  by  the  State  of  Israel,   for  the
cross-production  and sale of various small arms  ammunition,  we may or may not
incur increased spending on research and development  activities during Calendar
2004.

     Further, additional ammunition calibers and/or projectiles may be developed
by us depending upon market research,  acceptance in the marketplace of existing
products and  production  capabilities.  At this time,  there are no  definitive
plans for the further introduction of other new products into the marketplace.


Item 3 - Controls and Procedures

     As required by Rule 13a-15 under the Exchange Act, within the 90 days prior
to the filing date of this report,  the Company carried out an evaluation of the
effectiveness of the design and operation of the Company's  disclosure  controls
and  procedures.  This evaluation was carried out under the supervision and with
the  participation  of  the  Company's  President,  Chief  Executive  and  Chief
Financial Officer.  Based upon that evaluation,  the Company's President,  Chief
Executive and Chief Financial  Officer  concluded that the Company's  disclosure
controls and procedures are effective. There have been no significant changes in
the Company's internal controls or in other factors,  which could  significantly
affect  internal  controls  subsequent  to the date the Company  carried out its
evaluation.



                                       31




     Disclosure  controls and procedures are controls and other  procedures that
are  designed to ensure that  information  required to be  disclosed  in Company
reports  filed or  submitted  under the  Exchange  Act is  recorded,  processed,
summarized and reported, within the time periods specified in the Securities and
Exchange  Commission's  rules and  forms.  Disclosure  controls  and  procedures
include,  without  limitation,  controls and procedures  designed to ensure that
information required to be disclosed in Company reports filed under the Exchange
Act is accumulated and communicated to management, including the Company's Chief
Executive  Officer and Chief Financial  Officer as appropriate,  to allow timely
decisions regarding required disclosure.



                           Part II - Other Information


Item 1 - Legal Proceedings

   None


Item 2 - Recent Sales of Unregistered Securities and Use of Proceeds

     In  August  2004,   the  Company   issued  29,746  shares  of   restricted,
unregistered  common  stock  in  payment  of  approximately  $9,170  in  accrued
dividends payable on the Company's  outstanding Series B Preferred Stock for the
quarter  ended March 31,  2004.  The Company  relied  upon  Section  4(2) of the
Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in this transaction.

     In  October  2004,   the  Company   issued  53,908  shares  of  restricted,
unregistered  common  stock  in  payment  of  approximately  $9,170  in  accrued
dividends payable on the Company's  outstanding Series B Preferred Stock for the
quarter ended  September 30, 2004.  The Company  relied upon Section 4(2) of the
Securities Act of 1933, as amended,  for an exemption from registration of these
shares and no underwriter was used in this transaction.

     On October 19, 2004, the Company completed negotiations and closed an Asset
Purchase  Agreement by and between the Company,  Voluto Ventures LLC (a New York
limited  liability  company  and Voluto  Patent  Holding  Co.,  Inc. (a New York
corporation).  The Company acquired certain  machinery and equipment,  inventory
and the assignment of certain patents and  intellectual  property related to the
manufacture  and  production  of specialty  small-arms  ammunition.  The Company
issued  1,111,111  shares  of  restricted,  unregistered  common  stock  with an
agreed-upon value of $500,000 for this transaction.

     The sellers  agreed to  contractually  restrict their sale of the 1,111,111
shares of  restricted,  unregistered  common stock to an amount of up to 175,000
shares per month starting on April 28, 2005.



                                       32




Item 3 - Defaults on Senior Securities

   None


Item 4 - Submission of Matters to a Vote of Security Holders

   None


Item 5 - Other Information

   None


Item 6. Exhibits and Reports on Form 8-K

     (a) The exhibits  required to be filed  herewith by Item 601 of  Regulation
S-B, as described in the following index of exhibits, are incorporated herein by
reference, as follows:

Exhibit
number      Descriptions
---------   -----------------------

31.1        Certification pursuant to Section 302 of Sarbanes-Oxley Act of 2002.

32.1        Certification pursuant to Section 906 of Sarbanes-Oxley Act of 2002.


     (b) Reports on Form 8-K

        None



                                   SIGNATURES

     In accordance  with the  requirements  of the Exchange Act, the  registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                            American Ammunition, Inc.


Date: November 19, 2004

                                  By:     /s/ Andres F. Fernandez
                                  ----------------------------------
                                  Andres F. Fernandez
                                  President, Chief Executive Officer
                                  Chief Financial Officer and Director



                                       33